In a report released today, Brad Reback from Stifel Nicolaus maintained a Buy rating on JFrog (FROG – Research Report), with a price target of ...
Medicus Pharma (MDCX) announces that its phase 2 clinical study, SKNJCT-003, which is currently underway in nine clinical sites in United ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback